Package 76282-481-90

{"route": ["ORAL"], "spl_id": "9fff6e28-19e0-43ad-85c8-57d111b990bb", "openfda": {"upc": ["0376282481050", "0376282480053", "0376282481302", "0376282480305", "0376282480909", "0376282481906"], "unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["8a0781c0-e7d5-498e-b7d3-d6bd457f175f"], "manufacturer_name": ["Exelan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-481-05)", "package_ndc": "76282-481-05", "marketing_start_date": "20220210"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-481-30)", "package_ndc": "76282-481-30", "marketing_start_date": "20170612"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-481-90)", "package_ndc": "76282-481-90", "marketing_start_date": "20220210"}], "brand_name": "Bupropion Hydrochloride (XL)", "product_id": "76282-481_9fff6e28-19e0-43ad-85c8-57d111b990bb", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "76282-481", "generic_name": "bupropion hydrochloride", "labeler_name": "Exelan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "(XL)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA206556", "marketing_category": "ANDA", "marketing_start_date": "20170612", "listing_expiration_date": "20261231"}